| |
|
|
|
Corvus Pharma Com  
|
|
4.04 0.05 (0.01%) |
11-23 13:41 |
|
Open: |
3.98 |
Pre close: |
3.99 |
Target:
|
4.80
|
|
High: |
4.04 |
Low: |
3.9 |
Resistance:
|
4.11
4.30
|
|
Volume: |
103,164 |
Market Cap: |
113M |
Support:
|
3.79
3.15
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.07
 |
MACD |
MACD(12,26):
|
0.00 |
|
MA(20): |
4.07  |
Signal(12,26,9): |
0.02 |
|
MA(100): |
4.05 |
Stochastic Oscillator |
%K(14,3):
|
37.42 |
|
MA(250): |
3.77 |
%D(3): |
52.14 |
|
Average Volume(K) |
3-Month: |
94327
|
52-Week |
High:
|
6.88 |
|
10-Days: |
13495 |
Low: |
1.01 |
|
RSI |
RSI(14):
|
45.27 |
Change(%): |
35.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.509 |
Return on Equity (ttm) |
-72.3 |
Shares Out. (M) |
28.04 |
|
EPS Est. Current Year |
-3.180 |
Return on Assets (ttm) |
-38.2 |
Shares Float (M) |
14.55 |
|
EPS Est. Next Year |
-3.410 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.98 |
|
EPS Est. Next Quarter |
-0.840 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
67.80 |
|
Forward EPS |
-1.590 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1530 |
|
Book Value (p.s.) |
1.510 |
EBITDA (p.s.) |
-1.592 |
P/E |
-2.62 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.62 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-35.08 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-18.90 |
P/CF |
-3.16 |
|
|
|
|
|
|
